1.
J Okla State Med Assoc
; 105(11): 425-6, 2012 Nov.
Article
in English
| MEDLINE
| ID: mdl-23304899
Subject(s)
Adrenal Cortex Hormones/therapeutic use , Adrenergic beta-2 Receptor Antagonists/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Asthma, Exercise-Induced/prevention & control , Athletes , Bronchodilator Agents/therapeutic use , Administration, Inhalation , Adrenal Cortex Hormones/administration & dosage , Adrenergic beta-2 Receptor Antagonists/administration & dosage , Adrenergic beta-2 Receptor Antagonists/adverse effects , Albuterol/administration & dosage , Albuterol/therapeutic use , Androstadienes/administration & dosage , Androstadienes/therapeutic use , Anti-Inflammatory Agents/administration & dosage , Asthma, Exercise-Induced/drug therapy , Asthma, Exercise-Induced/physiopathology , Bronchodilator Agents/administration & dosage , Chemoprevention/methods , Clinical Trials as Topic , Fluticasone , Humans , Tachyphylaxis
2.
Community Ment Health J
; 38(5): 403-12, 2002 Oct.
Article
in English
| MEDLINE
| ID: mdl-12236410
ABSTRACT
Schizophrenia is viewed by most as having a neuropsychological component, with deficits primarily occurring in the areas of attention/concentration, memory, and executive functioning. These deficits often contribute to difficulties in everyday living and social functioning. The purpose of this study is to examine the efficacy of cognitive rehabilitation methods, typically utilized by brain-injured patients, to improve the executive functioning skills of patients with schizophrenia spectrum disorders. While this pilot study is limited in terms of sample size, results suggest that the addition of cognitive rehabilitation to the comprehensive treatment of schizophrenia could be beneficial in enhancing daily living skills.
